HIStalk Headlines: June 18, 2025
- Several health technology companies have recently secured significant funding to advance their respective innovations.
- Nabla, an ambient scribe technology vendor focused on agentic AI, has raised $70 million in a Series C funding round.
- Glytec, a diabetes management software vendor, announced $36 million in new funding.
Health tech funding is booming! Today’s HIStalk Headlines reveal considerable investments pouring into AI, diabetes management, and virtual therapy solutions. Nabla secured $70 million for its AI-powered scribe technology,while Glytec gained $36 million to advance diabetes tech. Additionally, Sword Health, a digital health startup, secured $40 million but delayed its IPO. These investments demonstrate ongoing confidence in health tech’s future, where innovative solutions improve patient care. Explore these developments, brought to you by News Directory 3, to stay ahead of the curve.What’s on the horizon for the future of health tech? discover what’s next …
Health Tech Funding Boost: AI, diabetes, Virtual Therapy
Several health technology companies have recently secured significant funding to advance their respective innovations. These investments span areas including artificial intelligence, diabetes management, and virtual physical therapy.
Nabla, an ambient scribe technology vendor focused on agentic AI, has raised $70 million in a Series C funding round. This brings their total funding to $120 million. Teh company aims to integrate its AI solutions into clinical workflows.
Glytec, a diabetes management software vendor, announced $36 million in new funding. The company plans to use the investment to accelerate innovation in its AI-powered diabetes technology platform. This role in diabetes care is expanding.
Sword Health, a digital health startup specializing in virtual physical therapy, pelvic healthcare, and mental healthcare, has secured $40 million. The company’s valuation now stands at $4 billion.However, Sword Health has postponed its IPO plans to at least 2028.
What’s next
these funding rounds highlight the continued investor interest in health technology companies that are developing innovative solutions to improve patient care and streamline clinical processes. The role of AI and virtual care is expected to grow.